Data Governance in Pharmaceutical Science and Technology

In Life Sciences, data is the new currency but only if it can be mined and retained at the highest quality; used properly, it can drive insights that improve research, operations, and outcomes. Pharmaceutical and biotechnology markets are poised to exceed $1.2 trillion by 2022. As data volumes continue to explode, opportunities, as well as challenges, emerge. Learn how one Pharma organization levered Semaphore and Semantic AI to manage their governance initiative.

Click here to download